CDT Equity (CDT) Cash from Operations (2022 - 2026)
CDT Equity's (CDT) quarterly Cash from Operations came in at 1894000.0 in Q1 2026, up 51.79% YoY from 1247740.78 in Q1 2025, and up 59.31% on a QoQ basis from 4655000.0 in Q4 2025.
CDT Equity (CDT) Cash from Operations (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Cash from Operations data on file, last reported at 1894000.0 in Q1 2026.
- Quarterly Cash from Operations rose 51.79% year-over-year to 1894000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13520000.0 (down 20.6% YoY) and the FY2025 annual result came in at 15555000.0, down 60.66% from the prior year.
- Cash from Operations climbed to 1894000.0 in Q1 2026, from 4655000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 126915.0 in Q2 2022 to a low of 4800000.0 in Q4 2023.
- A 5-year average of 2184176.47 and a median of 1970000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 433.33% — and 2026, when it soared 51.79%.
- Tracing CDT's Cash from Operations over 5 years: stood at 900000.0 in 2022, then tumbled by 433.33% to 4800000.0 in 2023, then advanced by 21.21% to 3782000.0 in 2024, then slipped by 23.08% to 4655000.0 in 2025, then surged by 59.31% to 1894000.0 in 2026.
- The last three Cash from Operations figures came in at 1894000.0 (Q1 2026), 4655000.0 (Q4 2025), and 4400000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 728.46 Mn |
| 10 | CDT Equity | 1.65 Mn | 1.65 Mn | - | -4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.34 Mn |
| Jun 30, 2026 | -4.34 Mn |
| Mar 31, 2026 | -1.89 Mn |
| Mar 31, 2026 | -1.89 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Sep 30, 2025 | -4.40 Mn |
| Sep 30, 2025 | -4.40 Mn |
| Jun 30, 2025 | -2.57 Mn |
| Jun 30, 2025 | -2.57 Mn |
| Mar 31, 2025 | -3.93 Mn |
| Mar 31, 2025 | -3.93 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | -1.50 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Mar 31, 2024 | -2.40 Mn |